@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-V72NPPQV-Z mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-SQ6QZ32T-C mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-PVLL6K0M-3
  skos:prefLabel "Antihistaminiques"@fr, "Histamine Antagonists"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-BZ89QH27-8 .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-FJWNX60N-2 mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-LD3NXJ47-1
  skos:prefLabel "Anti-Ulcer Agents"@en, "Antiulcéreux"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:related jvr:-BZ89QH27-8 .

jvr:-LB39D4ZX-S mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-LZV2LX4H-X mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-BZ89QH27-8
  mesh:allowableQualifier jvr:-HQRFT0C6-B, jvr:-WK5F724J-1, jvr:-H7K65Q8S-Z, jvr:-D0F21513-5, jvr:-G30ZJ446-J, jvr:-L6C0XPHT-4, jvr:-CB30NGKB-3, jvr:-T9HQD7ST-J, jvr:-NFTHND7Q-8, jvr:-THHNVC7V-3, jvr:-R3QWLHRG-V, jvr:-NKM836P1-M, jvr:-TJHVZCRZ-0, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-NB0XHT3S-N, jvr:-NHL3D2X0-S, jvr:-Q3979798-W, jvr:-W6SQV79N-S, jvr:-BT300B3G-Q, jvr:-S0CS1X5R-5, jvr:-XV06LPML-W ;
  skos:altLabel "Histamine H2 Receptor Blockaders"@en, "Histamine H2 Receptor Blockader"@en, "Histamine H2 Receptor Antagonist"@en, "H2 Receptor Blockader"@en, "Antagonists, Histamine H2"@en, "Blockaders, Histamine H2 Receptor"@en, "Antihistaminiques H2"@fr, "Histamine H2 Receptor Antagonists"@en, "Antihistaminiques du récepteur H2"@fr, "Receptor Blockaders, H2"@en, "Histamine H2 Blocker"@en, "Receptor Antagonists, Histamine H2"@en, "Antihistaminics, H2"@en, "Antagonistes des récepteurs histaminergiques H2"@fr, "H2 Receptor Blockaders"@en, "Antihistamines H2"@fr, "Anti-histamines H2"@fr, "Anti-histaminiques H2"@fr, "Histamine H2 Blockers"@en, "Histamine H2 Antagonist"@en, "Antagonistes H2"@fr ;
  dc:established "1977-01-01"^^xsd:date ;
  a skos:Concept, mesh:Descriptor ;
  skos:related jvr:-LD3NXJ47-1 ;
  skos:broader jvr:-PVLL6K0M-3 ;
  dc:created "1976-05-05"^^xsd:date ;
  skos:prefLabel "Histamine H2 Antagonists"@en, "Antihistaminiques des récepteurs H2"@fr ;
  dc:modified "2020-05-27"^^xsd:date ;
  skos:definition "Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood."@en ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D006635> ;
  skos:inScheme jvr: .

jvr:-GQ9PWBRF-Z mesh:pharmacologicalAction jvr:-BZ89QH27-8 .
jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .